Cardinal Health, Inc. $CAH Stock Purchased by Leuthold Group LLC

Leuthold Group LLC boosted its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 9.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 66,881 shares of the company's stock after purchasing an additional 5,806 shares during the period. Cardinal Health comprises 1.4% of Leuthold Group LLC's holdings, making the stock its 10th biggest holding. Leuthold Group LLC's holdings in Cardinal Health were worth $14,881,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Retirement Systems of Alabama grew its position in Cardinal Health by 2.7% in the 3rd quarter. Retirement Systems of Alabama now owns 386,632 shares of the company's stock valued at $86,026,000 after acquiring an additional 10,079 shares during the last quarter. Fulcrum Asset Management LLP increased its stake in Cardinal Health by 223.5% in the third quarter. Fulcrum Asset Management LLP now owns 226,820 shares of the company's stock worth $50,787,000 after purchasing an additional 156,704 shares during the period. RHL Group LLC increased its stake in Cardinal Health by 26.7% in the third quarter. RHL Group LLC now owns 475 shares of the company's stock worth $106,000 after purchasing an additional 100 shares during the period. M Holdings Securities Inc. bought a new stake in shares of Cardinal Health during the third quarter worth $1,235,000. Finally, Brighton Jones LLC lifted its position in shares of Cardinal Health by 1.7% during the third quarter. Brighton Jones LLC now owns 5,135 shares of the company's stock worth $1,143,000 after purchasing an additional 85 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $273.95 on Tuesday. The stock has a market cap of $63.44 billion, a price-to-earnings ratio of 35.44, a PEG ratio of 1.57 and a beta of 0.53. The firm's 50-day moving average is $241.24 and its two-hundred day moving average is $223.87. Cardinal Health, Inc. has a 1 year low of $180.45 and a 1 year high of $286.29.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported $3.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.94 by $0.32. The firm had revenue of $67.51 billion for the quarter, compared to the consensus estimate of $66.67 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The company's quarterly revenue was up 5.5% on a year-over-year basis. During the same period last year, the firm earned $2.55 earnings per share. On average, equities analysts expect that Cardinal Health, Inc. will post 12.86 earnings per share for the current year.

Insider Buying and Selling at Cardinal Health

In other news, CEO Jason Hollar sold 44,529 shares of Cardinal Health stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $236.18, for a total value of $10,516,859.22. Following the transaction, the chief executive officer directly owned 190,603 shares in the company, valued at approximately $45,016,616.54. This trade represents a 18.94% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Michelle Greene sold 11,650 shares of the business's stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $235.72, for a total value of $2,746,138.00. Following the completion of the transaction, the insider directly owned 10,330 shares of the company's stock, valued at approximately $2,434,987.60. The trade was a 53.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 210,271 shares of company stock worth $49,626,657. 0.12% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

CAH has been the topic of a number of research analyst reports. Citigroup upped their price target on shares of Cardinal Health from $265.00 to $280.00 and gave the stock a "buy" rating in a report on Wednesday, August 12th. Wall Street Zen raised shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Sunday, October 25th. Evercore restated an "outperform" rating and issued a $270.00 target price on shares of Cardinal Health in a research note on Wednesday, August 12th. Morgan Stanley raised their target price on shares of Cardinal Health from $265.00 to $286.00 and gave the stock an "overweight" rating in a research report on Friday, October 30th. Finally, Mizuho set a $290.00 target price on shares of Cardinal Health in a research report on Thursday. Sixteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $274.00.

Cardinal Health Profile

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers.

The company's businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations.

Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.